Cardiac Imaging

Which Study Should You Order for Aortic Coarctation When Echocardiography Is Inadequate?

A 17-year-old presents to your clinic with newly diagnosed hypertension. On exam, you note a significant brachial-femoral pulse delay and a systolic murmur best heard over the back. You order a transthoracic echocardiogram (TTE) to evaluate for aortic coarctation, but the report returns noting “technically difficult study with suboptimal acoustic windows; the aortic arch and descending aorta are inadequately visualized.” You still have a high clinical suspicion for coarctation but need a definitive diagnosis to guide management. What is the most appropriate next imaging study to order? This article provides a detailed workflow for this specific clinical scenario, grounded in the American College of Radiology (ACR) Appropriateness Criteria. For this presentation, the ACR rates MRA chest without and with IV contrast as Usually Appropriate.

Who Fits This Clinical Scenario for Suspected Aortic Coarctation?

This guidance applies to a specific patient population: any child or adult with a clinical suspicion of aortic coarctation for whom the initial, first-line imaging study—transthoracic echocardiography—was non-diagnostic or incomplete.

Inclusion criteria for this workflow:

  • Clinical signs suggestive of coarctation, such as upper extremity hypertension, diminished lower extremity pulses, a brachial-femoral pulse delay, or a characteristic systolic murmur.
  • A preceding transthoracic echocardiogram that failed to adequately visualize the aortic isthmus, descending aorta, or aortic arch, preventing a confident diagnosis or exclusion of coarctation.

Exclusion criteria (patients who should follow a different guideline):

  • Adequate initial echocardiogram: If the TTE was technically adequate and provided a definitive diagnosis, this workflow for next-step imaging does not apply.
  • Known coarctation post-repair: Patients with a history of surgical or endovascular repair of coarctation require surveillance imaging, which follows a different diagnostic algorithm.
  • Other primary complex congenital heart diseases: This guidance is not intended for patients with known complex conditions like repaired tetralogy of Fallot or transposition of the great arteries, even if aortic arch abnormalities are a concern. Those conditions have their own dedicated ACR Appropriateness Criteria variants.

This article is exclusively for the common clinical problem of choosing the next imaging test when the first one was inconclusive for a suspected primary diagnosis of aortic coarctation.

What Diagnoses Are You Working Up in This Scenario?

When ordering advanced imaging for suspected aortic coarctation, you are evaluating not just for the primary stenosis but also for a constellation of associated findings and potential mimics. The chosen study must be able to characterize this entire spectrum.

The primary target is, of course, aortic coarctation. This congenital narrowing of the aorta, most commonly located just distal to the origin of the left subclavian artery, obstructs blood flow to the lower body. The imaging study must precisely define the location, length, and severity of the stenotic segment.

Equally important is the assessment of associated cardiovascular anomalies. A bicuspid aortic valve is present in a majority of patients with coarctation and must be evaluated. Other potential associations include ventricular septal defects, patent ductus arteriosus, and hypoplasia of the transverse aortic arch. A comprehensive study should provide enough information to screen for these common concurrent conditions.

The imaging must also characterize the hemodynamic consequences, chiefly the development of collateral circulation. Significant coarctation forces blood through alternative pathways, such as the internal mammary and intercostal arteries. Visualizing these enlarged, tortuous collateral vessels confirms the physiologic significance of the narrowing.

Finally, the differential includes less common but important conditions. In adults, post-stenotic aortic dilatation or aneurysm formation is a critical finding that influences surgical planning and long-term risk. In some cases, particularly in young women, an acquired aortic narrowing from a large-vessel vasculitis like Takayasu arteritis can mimic congenital coarctation. Imaging features like vessel wall thickening can help differentiate between these etiologies.

Why Is MRA Chest the Recommended Next Study for Inadequate Echocardiography?

When TTE is inconclusive, both Magnetic Resonance Angiography (MRA) and Computed Tomography Angiography (CTA) provide excellent anatomic detail of the thoracic aorta. However, the ACR guidelines highlight MRA as a top choice due to its unique advantages in this specific patient population, which often includes children and young adults.

The ACR rates MRA chest without and with IV contrast as Usually Appropriate. Its key strength is the ability to provide high-resolution, three-dimensional anatomical detail of the aorta and its branches without using ionizing radiation (Relative Radiation Level: O 0 mSv). This is a paramount consideration in pediatric and young adult patients who may require lifelong surveillance imaging. The contrast-enhanced portion of the MRA delineates the vascular anatomy, precisely locating the coarctation and identifying associated aneurysms or collateral vessels. The non-contrast sequences, particularly phase-contrast imaging, can quantify blood flow and estimate the pressure gradient across the stenosis, providing crucial functional data that complements the anatomical findings. MRI heart function and morphology (with or without contrast) is also rated Usually Appropriate and can be performed in the same session to assess for associated cardiac anomalies like a bicuspid aortic valve and to evaluate ventricular function.

How do alternative studies compare?

  • CTA chest with IV contrast is also rated Usually Appropriate. It is significantly faster than MRA, making it a better choice for clinically unstable patients or those with contraindications to MRI (e.g., certain metallic implants, severe claustrophobia). However, it involves a notable radiation dose (adult RRL: ☢☢☢ 1-10 mSv; pediatric RRL: ☢☢☢☢ 3-10 mSv), making MRA the preferred option for stable patients, especially younger ones.
  • Transesophageal echocardiography (TEE) is rated Usually not appropriate as a next step. While excellent for evaluating intracardiac structures and the aortic valve, TEE often provides limited visualization of the distal aortic arch and descending thoracic aorta—the very regions that were likely poorly seen on the initial TTE. It is also more invasive than non-invasive cross-sectional imaging.

When ordering, specify the clinical indication clearly: “Suspected aortic coarctation with inadequate prior TTE. Please evaluate the entire thoracic aorta, arch vessels, and collateral circulation. If possible, quantify the gradient across any stenosis.”

What’s Next After MRA Chest? Downstream Workflow

The results of the MRA will guide your next steps, typically leading to a cardiology or cardiothoracic surgery consultation. The decision tree branches based on whether a significant coarctation is confirmed.

  • If the MRA is positive for significant coarctation: The primary next step is referral to a specialist center with expertise in congenital heart disease. The MRA findings—including the location and severity of the narrowing, the presence of an aneurysm, and the status of the aortic valve—will be used to plan for intervention. Treatment options include balloon angioplasty with or without stenting, or surgical repair. The choice of intervention depends on patient age, anatomy, and institutional expertise.
  • If the MRA is negative for coarctation: The workup for the patient’s presenting symptoms (e.g., hypertension) must continue. The focus shifts away from a structural cardiac cause. For a young patient with hypertension, this would typically involve an evaluation for renal or endocrine causes. The MRA effectively rules out a major vascular etiology for the presentation.
  • If the MRA is indeterminate or shows borderline findings: This is an uncommon outcome, but if the severity of a mild narrowing is unclear, further functional assessment may be needed. This could involve a cardiac catheterization, which is rated May be appropriate by the ACR. Catheterization allows for direct pressure measurements across the area of narrowing to definitively determine its hemodynamic significance before committing to an intervention.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for suspected aortic coarctation requires avoiding several common pitfalls that can delay diagnosis or lead to suboptimal imaging.

  • Pitfall 1: Repeating a limited study. Ordering another TTE after the first was technically inadequate is unlikely to yield a different result and only delays definitive diagnosis. Once acoustic windows are proven to be a limitation, move directly to cross-sectional imaging.
  • Pitfall 2: Forgetting about radiation in young patients. While CTA is an excellent test, defaulting to it without considering radiation-free MRA, especially in a child or young adult, is a significant oversight. Always weigh the radiation risk against the clinical urgency.
  • Pitfall 3: Not assessing for associated anomalies. The workup is incomplete if it only focuses on the coarctation itself. Ensure the ordered study is protocoled to also evaluate for a bicuspid aortic valve and other common intracardiac defects.
  • Pitfall 4: Misinterpreting a ductal bump. In neonates and infants, the remnant of the ductus arteriosus can create a “ductal bump” at the aortic isthmus that can be mistaken for a true coarctation. This requires experienced interpretation, often in consultation with a pediatric cardiologist or radiologist.

If there is any uncertainty in interpreting the imaging results or planning the next steps, especially regarding borderline findings or complex anatomy, escalate immediately by consulting with a cardiologist or congenital heart disease specialist.

Related ACR Topics and Tools

For further reading and to explore adjacent clinical scenarios, the following resources are available. The ACR Appropriateness Criteria are a comprehensive tool for evidence-based imaging decisions.

Frequently Asked Questions

Is MRA safe for all patients with suspected aortic coarctation?

MRA is very safe for most patients as it does not use ionizing radiation. However, it is contraindicated in patients with certain non-compatible metallic implants, such as older pacemakers, defibrillators, or cochlear implants. Patients with severe claustrophobia may also be unable to tolerate the long scan time. In these cases, CTA is the appropriate alternative.

Why is a chest radiograph rated ‘Usually not appropriate’ for this scenario?

While a chest radiograph might show suggestive signs of coarctation, such as rib notching (from enlarged intercostal collaterals) or the ‘3’ sign of the aorta, these findings are often absent, especially in younger patients. The radiograph cannot provide the detailed anatomical information needed to confirm the diagnosis or plan treatment. It is not a definitive study for this indication after a failed echocardiogram.

Do I need to order the MRA with and without contrast?

Yes, both components are valuable. The ACR lists ‘MRA chest without and with IV contrast’ as ‘Usually Appropriate’. The contrast-enhanced sequences provide the best anatomical roadmap of the aorta and collateral vessels. The non-contrast sequences, specifically phase-contrast imaging, can be used to measure blood flow velocity and calculate the pressure gradient across the coarctation, which helps determine its hemodynamic significance.

What if my patient is pregnant and has suspected coarctation?

This is a complex situation requiring multidisciplinary consultation. Non-contrast MRA is generally considered safe during pregnancy and would be the preferred next imaging step to avoid both radiation (from CT) and gadolinium-based contrast agents. Echocardiography, performed by an expert in adult congenital heart disease, would also be revisited. Gadolinium is typically avoided unless the potential benefit to the mother is deemed to outweigh the potential fetal risks.

Is CTA ever the first choice over MRA in a stable patient?

In a stable patient, particularly a child or young adult, MRA is almost always preferred due to the lack of ionizing radiation. However, CTA may be chosen first if MRA is not readily available, if the patient has a contraindication to MRI, or if there is a concurrent need to evaluate the coronary arteries, which are better visualized with high-resolution cardiac CTA.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026